GP2-114

CAS No. 130783-39-0

GP2-114( —— )

Catalog No. M33602 CAS No. 130783-39-0

GP2-114 is a catecholamine motility mimetic that produces current-dependent cardiovascular effects when administered via transdermal iontophoresis and can be used to study coronary artery disease (CAD).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1000 Get Quote
5MG 1216 Get Quote
10MG 2109 Get Quote
25MG 3947 Get Quote
50MG 5327 Get Quote
100MG 7065 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GP2-114
  • Note
    Research use only, not for human use.
  • Brief Description
    GP2-114 is a catecholamine motility mimetic that produces current-dependent cardiovascular effects when administered via transdermal iontophoresis and can be used to study coronary artery disease (CAD).
  • Description
    GP2-114 (GP-2-114) produces current-dependent cardiovascular action when administered by transdermal iontophoresis.
  • In Vitro
    A 50% mixture of the RR and RS distereoisomer forms of GP-2-128 (GP2-114) have the same pharmacologic profile as the pure RR distereoisomer.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    130783-39-0
  • Formula Weight
    344.4
  • Molecular Formula
    C19H24N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CNC(CCC1=CC=C(C(N)=O)C=C1)C)(O)C2=CC(O)=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Abou-Mohamed G, et al. J Cardiovasc Pharmacol. 1994 Mar;23(3):485-91. Integrative cardiovascular actions of a novel catecholamine, GP-2-128.?
molnova catalog
related products
  • 4-Hydroxybenzoic aci...

    4-Hydroxybenzoic acid is a monohydroxybenzoic acid, a phenolic derivative of benzoic acid. It is a white crystalline solid that is slightly soluble in water and chloroform but more soluble in polar organic solvents such as alcohols and acetone.

  • Pomalidomide-C9-COOH

    Pomalidomide-C9-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.

  • PTC299

    PTC299 (PTC-299) is a novel potent inhibitor of dihydroorotate dehydrogenase (DHODH), inhibits hypoxia-induced VEGFA protein production in HeLa cells with IC50 of 1.64 nM.